DETERMINATION OF TRIMIPRAMINE AND METABOLITES IN PLASMA BY LIQUID-CHROMATOGRAPHY WITH ELECTROCHEMICAL DETECTION

被引：38
作者：
SUCKOW, RF [1 ]
COOPER, TB [1 ]
机构：
[1] NEW YORK STATE PSYCHIAT INST,NEW YORK,NY 10032
来源：
JOURNAL OF PHARMACEUTICAL SCIENCES | 1984年 / 73卷 / 12期
关键词：
D O I：
10.1002/jps.2600731221
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
引用
收藏
页码：1745 / 1748
页数：4
相关论文
共 14 条
[1]   ELECTROANALYTICAL STUDY OF TRICYCLIC ANTIDEPRESSANTS [J].
BISHOP, E ;
HUSSEIN, W .
ANALYST, 1984, 109 (01) :73-80
[2]   STEADY-STATE PLASMA-CONCENTRATIONS OF CIS-10-OH AND TRANS-10-OH AMITRIPTYLINE METABOLITES [J].
BOCK, JL ;
GILLER, E ;
GRAY, S ;
JATLOW, P .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1982, 31 (05) :609-616
[3]   DESIPRAMINE HYDROXYLATION - VARIABILITY AND EFFECT OF ANTI-PSYCHOTIC DRUGS [J].
BOCK, JL ;
NELSON, JC ;
GRAY, S ;
JATLOW, PI .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1983, 33 (03) :322-328
[4]   PHARMACOKINETIC CHARACTERISTICS OF 2 DIFFERENT FORMULATIONS OF TRIMIPRAMINE DETERMINED WITH A NEW GLC METHOD [J].
CAILLE, G ;
BESNER, JG ;
LACASSE, Y ;
VEZINA, M .
BIOPHARMACEUTICS & DRUG DISPOSITION, 1980, 1 (04) :187-194
[5]  
COOPER TB, 1975, PSYCHOPHARMACOL COMM, V1, P445
[6]   PLASMA-CONCENTRATION MONITORING OF HYDROXYLATED METABOLITES OF IMIPRAMINE AND DESIPRAMINE [J].
DEVANE, CL ;
JUSKO, WJ .
DRUG INTELLIGENCE & CLINICAL PHARMACY, 1981, 15 (04) :263-266
[7]   ELECTROCHEMICAL OXIDATION OF IMINOBIBENZYL AND RELATED COMPOUNDS [J].
FRANK, SN ;
BARD, AJ ;
LEDWITH, A .
JOURNAL OF THE ELECTROCHEMICAL SOCIETY, 1975, 122 (07) :898-904
[8]   POLYMORPHIC HYDROXYLATION OF DEBRISOQUINE IN MAN [J].
MAHGOUB, A ;
IDLE, JR ;
DRING, LG ;
LANCASTER, R ;
SMITH, RL .
LANCET, 1977, 2 (8038) :584-586
[9]   ELECTROCHEMICAL OXIDATION OF HYDROXYLATED PHENOTHIAZINE AND IMIPRAMINE DERIVATIVES [J].
NEPTUNE, M ;
MCCREERY, RL ;
MANIAN, AA .
JOURNAL OF MEDICINAL CHEMISTRY, 1979, 22 (02) :196-199
[10]   ACTIVE METABOLITES OF IMIPRAMINE AND DESIPRAMINE IN MAN [J].
POTTER, WZ ;
CALIL, HM ;
SUTFIN, TA ;
ZAVADIL, AP ;
JUSKO, WJ ;
RAPOPORT, J ;
GOODWIN, FK .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1982, 31 (03) :393-401
12